Skip to main content

FBLG

Equity

FibroBiologics, Inc.

Health Care · Biotechnology

$0.33

+0.33 (+0.00%)

Open

N/A

Day Range

$0.30 - $0.33

52W Range

$0.22 - $1.53

Volume

1M

Price History

Key Statistics

Market Cap

N/A

P/E Ratio

N/A

EPS

N/A

Dividend Yield

N/A

P/B Ratio

N/A

Payout Ratio

N/A

ROE

N/A

Debt/Equity

N/A

Peers in Health Care

Symbol Name Price Mkt Cap Div Yield Change
ABCL AbCellera Biologics Inc. $3.61 N/A - +0.00%
ABUS Arbutus Biopharma Corporation $4.66 N/A - +0.00%
001540.KQ AHN-GOOK PHA $8,070.00 N/A 5.45% +0.00%
AKBA Akebia Therapeutics, Inc. $1.31 N/A - +0.00%
AHCO AdaptHealth Corp. $9.15 N/A - +0.00%
ABBV AbbVie Inc. $232.08 N/A 2.87% +0.00%
ACAD ACADIA Pharmaceuticals Inc. $24.56 N/A - +0.00%
CRSP CRISPR Therapeutics AG $60.14 N/A - +0.00%

Community Sentiment

Sign in to vote

0% Bullish 0% Neutral 100% Bearish

0 votes

Discussion (0)

Sign in to join the discussion

Loading comments...

About FibroBiologics, Inc.

FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases, including wound healing, multiple sclerosis, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applications. The company was founded in 2021 and is based in Houston, Texas.

fibrobiologics.com →

Dividend Safety

Assessment based on payout ratio, debt levels, profit margins, and dividend growth track record.

50

Borderline

Based on 4 fundamental factors

Share